Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Pharmaceuticals (Basel, Switzerland)|December 23, 2022
Post-Marketing Surveillance of Statins-A Descriptive Analysis of Psychiatric Adverse Reactions in EudraVigilanceGabriela Pop, Andreea Farcaș, Anca Butucă, et al.Antibiotics (Basel, Switzerland)|May 27, 2023
Adverse Drug Reactions Relevant to Drug Resistance and Ineffectiveness Associated with Meropenem, Linezolid, and Colistin: An Analysis Based on Spontaneous Reports from the European Pharmacovigilance DatabaseBogdan Ioan Vintila, Anca Maria Arseniu, Anca Butuca, et al.Journal of Clinical Medicine|March 27, 2025
Comparative Analysis of Neuropsychiatric Adverse Reactions Associated with Remdesivir and Nirmatrelvir/Ritonavir in COVID-19 Treatment: Insights from EudraVigilance DataAliteia-Maria Pacnejer, Mihaela Cristina Negru, Anca Maria Arseniu, et al.Molecules (Basel, Switzerland)|October 13, 2021
Dendrimers as Non-Viral Vectors in Gene-Directed Enzyme Prodrug TherapyAdriana Aurelia Chis, Carmen Maximiliana Dobrea, Luca-Liviu Rus, et al.Pharmaceutics|September 23, 2022
Biopolymeric Prodrug Systems as Potential Antineoplastic TherapyAdriana Aurelia Chis, Anca Maria Arseniu, Claudiu Morgovan, et al.Biomedicines|May 28, 2022
Microbial Resistance to Antibiotics and Effective AntibiotherapyAdriana Aurelia Chiș, Luca Liviu Rus, Claudiu Morgovan, et al.Molecules (Basel, Switzerland)|September 25, 2019
Design and Synthesis of Novel 1,3-Thiazole and 2-Hydrazinyl-1,3-Thiazole Derivatives as Anti-Candida Agents: In Vitro Antifungal Screening, Molecular Docking Study, and Spectroscopic Investigation of their Binding Interaction with Bovine Serum AlbuminAndreea-Iulia Pricopie, Ioana Ionuț, Gabriel Marc, et al.Pharmaceuticals (Basel, Switzerland)|January 28, 2026
Resistance, Ineffectiveness, and Off-Label Use Related to Cephalosporins from the Reserve Group-A Pharmacovigilance Signal Detection Study on EudraVigilance DatabaseAnca Maria Arseniu, Bogdan Ioan Vintila, Anca Butuca, et al.Pharmaceuticals (Basel, Switzerland)|October 26, 2024
Drug-Drug Interactions of Selective Serotonin Reuptake Inhibitors: A Pharmacovigilance Study on Real-World Evidence from the EudraVigilance DatabaseCarmen Maximiliana Dobrea, Adina Frum, Anca Butuca, et al.Pharmaceuticals (Basel, Switzerland)|November 25, 2023
A Pharmacovigilance Study Regarding the Risk of Antibiotic-Associated Clostridioides difficile Infection Based on Reports from the EudraVigilance Database: Analysis of Some of the Most Used Antibiotics in Intensive Care UnitsBogdan Ioan Vintila, Anca Maria Arseniu, Claudiu Morgovan, et al.Pageof 2